4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-22-007688
CHIEF EXECUTIVE OFFICER acquired 5,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2022-06-30 | Grant or award | +5,000 | $0.75 | $3,740 | 153,998 | D |
Loading xslF345X03/form4-07152022_040717.xml…